Literature DB >> 22718341

Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix.

Aileen M Barnes1, Wayne A Cabral, MaryAnn Weis, Elena Makareeva, Edward L Mertz, Sergey Leikin, David Eyre, Carlos Trujillo, Joan C Marini.   

Abstract

Recessive osteogenesis imperfecta (OI) is caused by defects in genes whose products interact with type I collagen for modification and/or folding. We identified a Palestinian pedigree with moderate and lethal forms of recessive OI caused by mutations in FKBP10 or PPIB, which encode endoplasmic reticulum resident chaperone/isomerases FKBP65 and CyPB, respectively. In one pedigree branch, both parents carry a deletion in PPIB (c.563_566delACAG), causing lethal type IX OI in their two children. In another branch, a child with moderate type XI OI has a homozygous FKBP10 mutation (c.1271_1272delCCinsA). Proband FKBP10 transcripts are 4% of control and FKBP65 protein is absent from proband cells. Proband collagen electrophoresis reveals slight band broadening, compatible with ≈10% over-modification. Normal chain incorporation, helix folding, and collagen T(m) support a minimal general collagen chaperone role for FKBP65. However, there is a dramatic decrease in collagen deposited in culture despite normal collagen secretion. Mass spectrometry reveals absence of hydroxylation of the collagen telopeptide lysine involved in cross-linking, suggesting that FKBP65 is required for lysyl hydroxylase activity or access to type I collagen telopeptide lysines, perhaps through its function as a peptidylprolyl isomerase. Proband collagen to organics ratio in matrix is approximately 30% of normal in Raman spectra. Immunofluorescence shows sparse, disorganized collagen fibrils in proband matrix. Published 2012 Wiley Periodicals, Inc.*This article is a US Government work and, as such, is in the public domain of the United States of America.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718341      PMCID: PMC3470738          DOI: 10.1002/humu.22139

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  42 in total

1.  Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix.

Authors:  M Valli; A M Barnes; A Gallanti; W A Cabral; S Viglio; M A Weis; E Makareeva; D Eyre; S Leikin; F Antoniazzi; J C Marini; M Mottes
Journal:  Clin Genet       Date:  2011-10-19       Impact factor: 4.438

2.  Biochemical changes in the collagen of human osteoporotic bone matrix.

Authors:  A J Bailey; S F Wotton; T J Sims; P W Thompson
Journal:  Connect Tissue Res       Date:  1993       Impact factor: 3.417

3.  Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta.

Authors:  S D Chessler; G A Wallis; P H Byers
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

4.  Collagen self-assembly in vitro. Differentiating specific telopeptide-dependent interactions using selective enzyme modification and the addition of free amino telopeptide.

Authors:  D L Helseth; A Veis
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

5.  Developmental regulation of FKBP65. An ER-localized extracellular matrix binding-protein.

Authors:  C E Patterson; T Schaub; E J Coleman; E C Davis
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

6.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

7.  Deposition and selective degradation of structurally-abnormal type I collagen in a collagen matrix produced by osteogenesis imperfecta fibroblasts in vitro.

Authors:  J F Bateman; S B Golub
Journal:  Matrix Biol       Date:  1994-04       Impact factor: 11.583

8.  Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase.

Authors:  B Steinmann; P Bruckner; A Superti-Furga
Journal:  J Biol Chem       Date:  1991-01-15       Impact factor: 5.157

9.  Hsp47 and cyclophilin B traverse the endoplasmic reticulum with procollagen into pre-Golgi intermediate vesicles. A role for Hsp47 and cyclophilin B in the export of procollagen from the endoplasmic reticulum.

Authors:  T Smith; L R Ferreira; C Hebert; K Norris; J J Sauk
Journal:  J Biol Chem       Date:  1995-08-04       Impact factor: 5.157

10.  Molecular cloning, DNA sequence analysis, and biochemical characterization of a novel 65-kDa FK506-binding protein (FKBP65).

Authors:  M C Coss; D Winterstein; R C Sowder; S L Simek
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

View more
  46 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

Review 2.  Contributions of Raman spectroscopy to the understanding of bone strength.

Authors:  Gurjit S Mandair; Michael D Morris
Journal:  Bonekey Rep       Date:  2015-01-07

3.  FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.

Authors:  Claudia A Staab-Weijnitz; Isis E Fernandez; Larissa Knüppel; Julia Maul; Katharina Heinzelmann; Brenda M Juan-Guardela; Elisabeth Hennen; Gerhard Preissler; Hauke Winter; Claus Neurohr; Rudolf Hatz; Michael Lindner; Jürgen Behr; Naftali Kaminski; Oliver Eickelberg
Journal:  Am J Respir Crit Care Med       Date:  2015-08-15       Impact factor: 21.405

4.  Resurrecting the protein fold for disease intervention.

Authors:  Richard N Sifers
Journal:  Chem Biol       Date:  2013-03-21

5.  A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation.

Authors:  Caressa D Lietman; Ronit Marom; Elda Munivez; Terry K Bertin; Ming-Ming Jiang; Yuqing Chen; Brian Dawson; Mary Ann Weis; David Eyre; Brendan Lee
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

6.  Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)-G610C Mouse Model of Osteogenesis Imperfecta.

Authors:  Lynn S Mirigian; Elena Makareeva; Edward L Mertz; Shakib Omari; Anna M Roberts-Pilgrim; Arin K Oestreich; Charlotte L Phillips; Sergey Leikin
Journal:  J Bone Miner Res       Date:  2016-04-13       Impact factor: 6.741

7.  A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis.

Authors:  Yoshihiro Ishikawa; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2014-05-12       Impact factor: 5.157

8.  COL1A1 C-propeptide mutations cause ER mislocalization of procollagen and impair C-terminal procollagen processing.

Authors:  Aileen M Barnes; Aarthi Ashok; Elena N Makareeva; Marina Brusel; Wayne A Cabral; MaryAnn Weis; Catherine Moali; Emmanuel Bettler; David R Eyre; John P Cassella; Sergey Leikin; David J S Hulmes; Efrat Kessler; Joan C Marini
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-05-02       Impact factor: 5.187

9.  Osteogenesis imperfecta Type XI: A rare cause of severe infantile cervical kyphosis.

Authors:  Jane L Ferguson; Susan R J Burrows
Journal:  Radiol Case Rep       Date:  2020-09-03

10.  Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations.

Authors:  Aileen M Barnes; Geraldine Duncan; Maryann Weis; William Paton; Wayne A Cabral; Edward L Mertz; Elena Makareeva; Michael J Gambello; Felicitas L Lacbawan; Sergey Leikin; Andrzej Fertala; David R Eyre; Sherri J Bale; Joan C Marini
Journal:  Hum Mutat       Date:  2013-07-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.